Current perspectives on the pathogenesis of multiple sclerosis: A minireview
References
- Adamec I, Krbot Skoric M, Habek M. Peripheral nervous system in multiple sclerosis-understanding the involvement via autonomic nervous system. Neurol Sci 42, 2731–2736, 2021.
- Alissafi T, Kalafati L, Lazari M, Filia A, Kloukina I, Manifava M, Lim JH, Alexaki VI, Ktistakis NT, Doskas T, Garinis GA, Chavakis T, Boumpas DT, Verginis P. Mitochondrial oxidative damage underlies regulatory T cell defects in autoimmunity. Cell Metab 32, 591–604.e7, 2020.
- Ammar RA, Mohamed AF, Kamal MM, Safar MM, Abdelkader NF. Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome. Inflammopharmacology 30, 919–934, 2022.
- Bartekova M, Adameova A, Gorbe A, Ferenczyova K, Pechanova O, Lazou A, Dhalla NS, Ferdinandy P, Giricz Z. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. Free Radic Biol Med 169, 446–477, 2021.
- Boutitah-Benyaich I, Eixarch H, Villacieros-Alvarez J, Hervera A, Cobo-Calvo A, Montalban X, Espejo C. Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Ther 10, 324, 2025.
- Bray JJH, Foster‐Davies H, Salem A, Hoole AL, Obaid DR, Halcox JPJ, Stephens JW. Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials. Diabetes Obes Metab 23, 1806–1822, 2021.
- Cacciapaglia F, Spinelli FR, Piga M, Erre GL, Sakellariou G, Manfredi A, Viapiana O, Fornaro M, Colella S, Floris A, Mangoni AA, Castagna F, Vacchi C, Orsolini G, Bugatti S, Cafaro G, Cauli A, Gremese E, Atzeni F, Bartoloni E. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group. Eur J Intern Med 96, 60–65, 2022.
- Chiesa ST, Charakida M. High-density lipoprotein function and dysfunction in health and disease. Cardiovasc Drugs Ther 33, 207–219, 2019.
- Compston A, Coles A. Multiple sclerosis. Lancet 372, 1502–1517, 2008.
- Compston A. Occasional essay: Multiple sclerosis in the digital age: ‘seeing through a glass darkly’. J Neurol Neurosurg Psychiatry 91, 1017–1023, 2020.
- Cunniffe N, Coles A. Promoting remyelination in multiple sclerosis. J Neurol 268, 30–44, 2021.
- De Riccardis L, Rizzello A, Ferramosca A, Urso E, De Robertis F, Danieli A, Giudetti AM, Trianni G, Zara V, Maffia M. Bioenergetics profile of CD4 + T cells in relapsing remitting multiple sclerosis subjects. J Biotechnol 202, 31–39, 2015.
- DellaValle B, Brix GS, Brock B, Gejl M, Landau AM, Moller A, Rungby J, Larsen A. Glucagon-like peptide-1 analog, liraglutide, delays onset of experimental autoimmune encephalitis in Lewis rats. Front Pharmacol 7, 433, 2016.
- Dimitriadou EM, Tzanetakos D, Theodorou A, Akrivaki A, Papadopoulos D, Mastorodemos V, Maleska A, Sotirli SA, Fakas N, Stergiou C, Kitsos D, Giannopapas V, Moschovos C, Giannopoulos S, Kuhle J, Tsivgoulis G, Tzartos JS. The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naive patients with multiple sclerosis. J Neurol 273, 194, 2026.
- Dong Y, Yong VW. Oxidized phospholipids as novel mediators of neurodegeneration. Trends Neurosci 45, 419–429, 2022.
- Filipek B, Macieja A, Poplawski T. Impaired DNA repair of oxidative damage in CD4+ and CD8+ T but not B cells isolated from patients with multiple sclerosis (P6-1.007). Neurology 104, 2561, 2025.
- Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA. Multiple sclerosis. Nat Rev Dis Primers 4, 43, 2018.
- Findling O, Hauer L, Pezawas T, Rommer PS, Struhal W, Sellner J. Cardiac autonomic dysfunction in multiple sclerosis: a systematic review of current knowledge and impact of immunotherapies. J Clin Med 9, 335, 2020.
- Fogelman AM. Further evidence that high-density lipoprotein is a chameleon-like lipoprotein. Eur Heart J 36, 3017–3019, 2015.
- Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, Wang J, Ke Y, Hu H, Cao X, Wang D, Cantor H, Gao X, Lu L. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med 214, 1453–1469, 2017.
- Gonzalo H, Nogueras L, Gil-Sanchez A, Hervas JV, Valcheva P, Gonzalez-Mingot C, Martin-Gari M, Canudes M, Peralta S, Solana MJ, Pamplona R, Portero-Otin M, Boada J, Serrano JCE, Brieva L. Impairment of mitochondrial redox status in peripheral lymphocytes of multiple sclerosis patients. Front Neurosci 13, 938, 2019.
- Gulow K, Tumen D, Heumann P, Schmid S, Kandulski A, Muller M, Kunst C. Unraveling the role of reactive oxygen species in T lymphocyte signaling. Int J Mol Sci 25, 6114, 2024.
- Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H. Oxidative damage in multiple sclerosis lesions. Brain 134, 1914–1924, 2011.
- Hardonova M, Siarnik P, Sivakova M, Sucha B, Vlcek M, Imrich R, Turcani P, Havranova A, Radikova Z, Zitnanova I, Dean Z, Penesova A, Kollar B. Autonomic nervous system function in newly diagnosed multiple sclerosis: association with lipid levels and insulin resistance. Physiol Res 70, 875–882, 2021.
- Hardonova M, Siarnik P, Sivakova M, Sucha B, Penesova A, Radikova Z, Havranova A, Imrich R, Vlcek M, Zitnanova I, Krastev G, Kiacikova M, Kollar B, Turcani P. Endothelial function in patients with multiple sclerosis: the role of GLP-1 agonists, lipoprotein subfractions, and redox balance. Int J Mol Sci 24, 11162, 2023.
- Imrich R, Vlcek M, Penesova A, Radikova Z, Havranova A, Sivakova M, Siarnik P, Kollar B, Sokolov T, Turcani P, Heckova E, Hangel G, Strasser B, Bogner W. Cardiac autonomic function in patients with early multiple sclerosis. Clin Auton Res 31, 553–562, 2021.
- Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben J-P, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJA. Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. Sci Rep 7, 43410, 2017.
- Kemenyova P, Siarnik P, Sutovsky S, Blaho A, Turcani P, Kollar B. Impairment of endothelial function in patients with multiple sclerosis. Neuro Endocrinol Lett 36, 67–71, 2015.
- Khosravi M, Poursaleh A, Ghasempour G, Farhad S, Najafi M. The effects of oxidative stress on the development of atherosclerosis. Biol Chem 400, 711–732, 2019.
- Kirov II, Liu S, Tal A, Wu WE, Davitz MS, Babb JS, Rusinek H, Herbert J, Gonen O. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady‐state metabolism and its relationship to conventional imaging. Hum Brain Mapp 38, 4047–4063, 2017.
- Kollar B, Blaho A, Valovicova K, Poddany M, Valkovic P, Straka I, Turcani P, Siarnik P. Impairment of endothelial function in Parkinson’s disease. BMC Res Notes 15, 284, 2022.
- Kuutti K, Laakso SM, Viitala M, Atula S, Soilu-Hanninen M. Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study. J Neurol 272, 370, 2025.
- Lappegard KT, Kjellmo CA, Hovland A. High-density lipoprotein subfractions: much ado about nothing or clinically important? Biomedicines 9, 836, 2021.
- Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P. Oxidative stress, aging, and diseases. Clin Interv Aging 13, 757–772, 2018.
- Lorkowski SW, Smith JD. HDL is not dead yet. Biomedicines 10, 128, 2022.
- Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Bark-hof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 83, 278–286, 2014.
- Moser T, Akgun K, Proschmann U, Sellner J, Ziemssen T. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun Rev 19, 102647, 2020.
- Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res 120, 229–243, 2017.
- Ortiz GG, Macias-Islas MA, Pacheco-Moises FP, Cruz-Ramos JA, Sustersik S, Barba EA, Aguayo A. Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Dis Markers 26, 35–39, 2009.
- Padureanu R, Albu CV, Mititelu RR, Bacanoiu MV, Docea AO, Calina D, Padureanu V, Olaru G, Sandu RE, Malin RD, Buga AM. Oxidative stress and inflammation interdependence in multiple sclerosis. J Clin Med 8, 1815, 2019.
- Palladino R, Marrie RA, Majeed A, Chataway J. Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England. JAMA Neurol 77, 820–828, 2020.
- Pegoretti V, Swanson KA, Bethea JR, Probert L, Eisel ULM, Fischer R. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid Med Cell Longev 2020, 7191080, 2020.
- Penesova A, Vlcek M, Imrich R, Vernerova L, Marko A, Meskova M, Grunnerova L, Turcani P, Jezova D, Kollar B. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis. Metab Brain Dis 30, 895–901, 2015.
- Penesova A, Dean Z, Kollar B, Havranova A, Imrich R, Vlcek M, Radikova Z. Nutritional intervention as an essential part of multiple sclerosis treatment? Physiol Res 67, 521–533, 2018.
- Petruzzo M, Reia A, Maniscalco GT, Luiso F, Lanzillo R, Russo CV, Carotenuto A, Allegorico L, Palladino R, Brescia Morra V, Moccia M. The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis. Eur J Neurol 28, 893–900, 2021.
- Racosta JM, Kimpinski K. Autonomic dysfunction, immune regulation, and multiple sclerosis. Clin Auton Res 26, 23–31, 2016.
- Radikova Z, Penesova A, Vlcek M, Havranova A, Sivakova M, Siarnik P, Zitnanova I, Imrich R, Kollar B, Turcani P. LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity. Endocr Regul 52, 139–145, 2018.
- Radikova Z, Penesova A, Vlcek M, Havranova A, Sivakova M, Siarnik P, Zitnanova I, Imrich R, Turcani P, Kollar B. Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation? Lipids Health Dis 19, 49, 2020.
- Rey F, Ottolenghi S, Zuccotti G, Samaja M, Carelli S. Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects. Neural Regen Res 17, 754, 2022.
- Rizvi AA, Stoian AP, Janez A, Rizzo M. Lipoproteins and cardiovascular disease: an update on the clinical significance of atherogenic small, dense LDL and new therapeutical options. Biomedicines 9, 1579, 2021.
- Rodrigues P, Bochi GV, Trevisan G. Advanced oxidative protein products role in multiple sclerosis: a systematic review and meta-analysis. Mol Neurobiol 58, 5724–5742, 2021.
- Rubino V, Palatucci AT, La Rosa G, Giovazzino A, Aruta F, Damiano S, Carriero F, Santillo M, Iodice R, Mondola P, Ruggiero G, Terrazzano G. Superoxide dismutase-1 intracellular content in T lymphocytes associates with increased regulatory T cell level in multiple sclerosis subjects undergoing immune-modulating Treatment. Antioxidants 10, 1940, 2021.
- Ryan L, Mills KHG. Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis. Eur J Immunol 52, 24–33, 2022.
- Sanabria-Castro A, Alape-Giron A, Flores-Diaz M, Echeverri-McCandless A, Parajeles-Vindas A. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review. Rev Neurosci 35, 355–371, 2024.
- Siddiqui K, Browne RW, Benedict RHB, Jakimovski D, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis. Mult Scler Relat Disord 69, 104374, 2023.
- Sirbu C, Mezei RM, Falup-Pecurariu C, Bratu O, Sirbu A, Ghinescu M, Radu F. Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice (Review). Exp Ther Med 20, 196, 2020.
- Sivakova M, Siarnik P, Filippi P, Vlcek M, Imrich R, Turcani P, Zitnanova I, Penesova A, Radikova Z, Kollar B. Oxidative stress in patients with newly diagnosed multiple sclerosis: any association with subclinical atherosclerosis? Neuro Endocrinol Lett 40, 135–140, 2019.
- Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet 391, 1622–1636, 2018.
- Van Noort JM, Baker D, Kipp M, Amor S. The pathogenesis of multiple sclerosis: a series of unfortunate events. Clin Exp Immunol 214, 1–17, 2023.
- Vanhoutte PM, Shimokawa H, Feletou M, Tang EHC. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol 219, 22–96, 2017.
- Villar-Delfino PH, Gomes NAO, Christo PP, Nogueira-Machado JA, Volpe CMO. Edaravone inhibits the production of reactive oxygen species in phagocytosis- and PKC-stimulated granulocytes from multiple sclerosis patients Edaravone modulate oxidative stress in multiple sclerosis. J Cent Nerv Syst Dis 14, 11795735221092524, 2022.
- Yang F, Hu T, He K, Ying J, Cui H. Multiple sclerosis and the risk of cardiovascular diseases: a Mendelian randomization Study. Front Immunol 13, 861885, 2022.
- Yevgi R, Demir R. Oxidative stress activity of fingolimod in multiple sclerosis. Clin Neurol Neurosurg 202, 106500, 2021.
- Yuksel B, Koc P, Ozaydin Goksu E, Karacay E, Kurtulus F, Cekin Y, Bicer Gomceli Y. Is multiple sclerosis a risk factor for atherosclerosis? J Neuroradiol 48, 99–103, 2021.
- Zhang D, Jin W, Wu R, Li J, Park SA, Tu E, Zanvit P, Xu J, Liu O, Cain A, Chen W. High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-β cytokine activation. Immunity 51, 671‒681. e5, 2019.
- Zierfuss B, Larochelle C, Prat A. Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies. Lancet Neurol 23, 95–109, 2024.
Language: English
Page range: 72 - 85
Published on: Jun 27, 2026
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Zofia Radikova, Miroslav Tibensky, Lucia Mosna, Adela Penesova, Andrea Havranova, Miroslav Vlcek, Richard Imrich, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.